{"id":"https://openalex.org/W4385288317","doi":"https://doi.org/10.2147/copd.s418944","title":"Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis","display_name":"Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis","publication_year":2023,"publication_date":"2023-07-01","ids":{"openalex":"https://openalex.org/W4385288317","doi":"https://doi.org/10.2147/copd.s418944","pmid":"https://pubmed.ncbi.nlm.nih.gov/37533773"},"language":"en","primary_location":{"id":"doi:10.2147/copd.s418944","doi":"https://doi.org/10.2147/copd.s418944","is_oa":true,"landing_page_url":"https://doi.org/10.2147/copd.s418944","pdf_url":"https://www.dovepress.com/getfile.php?fileID=91526","source":{"id":"https://openalex.org/S105319247","display_name":"International Journal of COPD","issn_l":"1176-9106","issn":["1176-9106","1178-2005"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Chronic Obstructive Pulmonary Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=91526","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068917661","display_name":"Dave Singh","orcid":"https://orcid.org/0000-0001-8918-7075","observed_orcids":["https://orcid.org/0000-0001-8918-7075"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210092852","display_name":"Manchester University NHS Foundation Trust","ror":"https://ror.org/00he80998","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Dave Singh","raw_affiliation_strings":["Manchester University NHS Foundation Hospital Trust, the University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Manchester University NHS Foundation Hospital Trust, the University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210092852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009003396","display_name":"Gerard J. Criner","orcid":"https://orcid.org/0000-0003-1267-3483","observed_orcids":["https://orcid.org/0000-0003-1267-3483"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerard J Criner","raw_affiliation_strings":["Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I84392919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054165025","display_name":"Alvar G.N. Agust\u00ed","orcid":"https://orcid.org/0000-0003-3271-3788","observed_orcids":["https://orcid.org/0000-0003-3271-3788"]},"institutions":[{"id":"https://openalex.org/I4210099160","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Respiratorias","ror":"https://ror.org/0119pby33","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210099160","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alvar Agust\u00ed","raw_affiliation_strings":["Respiratory Institute (Hospital Clinic), IDIBAPS, CIBERES, Catedra Salud Respiratoria (University of Barcelona), Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Respiratory Institute (Hospital Clinic), IDIBAPS, CIBERES, Catedra Salud Respiratoria (University of Barcelona), Barcelona, Spain","institution_ids":["https://openalex.org/I4210099160","https://openalex.org/I4210160192","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021121714","display_name":"Mona Bafadhel","orcid":"https://orcid.org/0000-0002-9993-2478","observed_orcids":["https://orcid.org/0000-0002-9993-2478"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mona Bafadhel","raw_affiliation_strings":["School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080012368","display_name":"Johan S\u00f6derstr\u00f6m","orcid":"https://orcid.org/0009-0002-0858-623X","observed_orcids":["https://orcid.org/0009-0002-0858-623X"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Johan S\u00f6derstr\u00f6m","raw_affiliation_strings":["Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":"https://orcid.org/0009-0002-0858-623X","affiliations":[{"raw_affiliation_string":"Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085417988","display_name":"Gabriela Luporini Saraiva","orcid":"https://orcid.org/0000-0002-2131-8013","observed_orcids":["https://orcid.org/0000-0002-2131-8013"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela Luporini Saraiva","raw_affiliation_strings":["Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":"https://orcid.org/0000-0002-2131-8013","affiliations":[{"raw_affiliation_string":"Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100780800","display_name":"Yue Song","orcid":"https://orcid.org/0009-0002-6488-9956","observed_orcids":["https://orcid.org/0009-0002-6488-9956"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yue Song","raw_affiliation_strings":["Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026702908","display_name":"Idlir Licaj","orcid":"https://orcid.org/0000-0003-3389-0735","observed_orcids":["https://orcid.org/0000-0003-3389-0735"]},"institutions":[{"id":"https://openalex.org/I95746587","display_name":"Cytel (United States)","ror":"https://ror.org/01ftkxq60","country_code":"US","type":"company","lineage":["https://openalex.org/I95746587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Idlir Licaj","raw_affiliation_strings":["Cytel Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytel Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I95746587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060008921","display_name":"Maria L. Jison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Jison","raw_affiliation_strings":["Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077936927","display_name":"Ubaldo J. Martin","orcid":"https://orcid.org/0000-0002-0089-7677","observed_orcids":["https://orcid.org/0000-0002-0089-7677"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ubaldo J Martin","raw_affiliation_strings":["Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048009571","display_name":"Ioannis Psallidas","orcid":"https://orcid.org/0000-0001-7284-0111","observed_orcids":["https://orcid.org/0000-0001-7284-0111"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ioannis Psallidas","raw_affiliation_strings":["Late-Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Late-Stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":4.0155,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.95111086,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"Volume 18","issue":null,"first_page":"1595","last_page":"1599"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benralizumab","display_name":"benralizumab","score":1.0},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acute-exacerbation-of-copd","display_name":"COPD exacerbations","score":0.984000027179718},{"id":"https://openalex.org/keywords/recurrent-exacerbations","display_name":"recurrent exacerbations","score":0.828000009059906},{"id":"https://openalex.org/keywords/blood-eosinophils","display_name":"blood eosinophils","score":0.8309999704360962},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.6809999942779541},{"id":"https://openalex.org/keywords/exacerbation-prevention","display_name":"exacerbation prevention","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9624061584472656},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.8753721714019775},{"id":"https://openalex.org/C2777014857","wikidata":"https://www.wikidata.org/wiki/Q1383410","display_name":"Exacerbation","level":2,"score":0.7733277082443237},{"id":"https://openalex.org/C2779185760","wikidata":"https://www.wikidata.org/wiki/Q3638304","display_name":"Benralizumab","level":5,"score":0.7288587093353271},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.48297634720802307},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.47665172815322876},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.455698162317276},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.45096734166145325},{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.14978939294815063},{"id":"https://openalex.org/C2777037409","wikidata":"https://www.wikidata.org/wiki/Q107238","display_name":"Eosinophil","level":3,"score":0.14229470491409302},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.10576385259628296},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.2147/copd.s418944","doi":"https://doi.org/10.2147/copd.s418944","is_oa":true,"landing_page_url":"https://doi.org/10.2147/copd.s418944","pdf_url":"https://www.dovepress.com/getfile.php?fileID=91526","source":{"id":"https://openalex.org/S105319247","display_name":"International Journal of COPD","issn_l":"1176-9106","issn":["1176-9106","1178-2005"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Chronic Obstructive Pulmonary Disease","raw_type":"journal-article"},{"id":"pmid:37533773","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37533773","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of chronic obstructive pulmonary disease","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/85473","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/benralizumab-prevents-recurrent-exacerbations-in-patients-with-chronic-peer-reviewed-fulltext-article-COPD","pdf_url":"https://www.dovepress.com/article/download/85473","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Short Report"},{"id":"pmh:oai:kclpure.kcl.ac.uk:openaire/c3e0d819-1dc1-445a-a7ef-da68b7e59e0f","doi":null,"is_oa":true,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/c3e0d819-1dc1-445a-a7ef-da68b7e59e0f","pdf_url":"https://kclpure.kcl.ac.uk/ws/files/350948702/Benralizumab_Prevents_Recurrent_Exacerbations_SINGH_Publishedonline27July2023_GOLD_VoR_CC_BY-NC_.pdf","source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Singh, D, Criner, G J, Agust\u00ed, A, Bafadhel, M, S\u00f6derstr\u00f6m, J, Saraiva, G L, Song, Y, Licaj, I, Jison, M, Martin, U J & Psallidas, I 2023, 'Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease : A Post Hoc Analysis', International Journal of COPD, vol. 18, pp. 1595-1599. https://doi.org/10.2147/COPD.S418944","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10390712","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10390712","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10390712/pdf/copd-18-1595.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Int J Chron Obstruct Pulmon Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.2147/copd.s418944","doi":"https://doi.org/10.2147/copd.s418944","is_oa":true,"landing_page_url":"https://doi.org/10.2147/copd.s418944","pdf_url":"https://www.dovepress.com/getfile.php?fileID=91526","source":{"id":"https://openalex.org/S105319247","display_name":"International Journal of COPD","issn_l":"1176-9106","issn":["1176-9106","1178-2005"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Chronic Obstructive Pulmonary Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"No poverty","score":0.6200000047683716,"id":"https://metadata.un.org/sdg/1"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7275711376","display_name":null,"funder_award_id":"GPP 2022","funder_id":"https://openalex.org/F4320307770","funder_display_name":"AstraZeneca"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385288317.pdf","grobid_xml":"https://content.openalex.org/works/W4385288317.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1868068011","https://openalex.org/W1993396326","https://openalex.org/W2031162656","https://openalex.org/W2055397397","https://openalex.org/W2065797637","https://openalex.org/W2073959308","https://openalex.org/W2120018683","https://openalex.org/W2946719800","https://openalex.org/W2975842537","https://openalex.org/W3023067104","https://openalex.org/W3203557682","https://openalex.org/W4294967892"],"related_works":["https://openalex.org/W3215777588","https://openalex.org/W3031048816","https://openalex.org/W2883503418","https://openalex.org/W2551156725","https://openalex.org/W2883290332","https://openalex.org/W2991954549","https://openalex.org/W2755334065","https://openalex.org/W2780015465","https://openalex.org/W2951336120","https://openalex.org/W4283315890"],"abstract_inverted_index":{"Exacerbations":[0],"in":[1,11,53,86,105],"chronic":[2],"obstructive":[3],"pulmonary":[4],"disease":[5,16],"(COPD),":[6],"which":[7,106],"tend":[8],"to":[9,129],"occur":[10],"clusters":[12],"and":[13,22,26,34,44,96,116,141,160],"increase":[14],"with":[15,19,40,55,108],"severity,":[17],"come":[18],"high":[20,137],"societal":[21],"economic":[23],"burdens.":[24],"Prevention":[25],"delay":[27],"of":[28,51,78,84,93,154,167],"recurrent":[29,111],"exacerbations":[30,58,80,113,144],"is":[31],"an":[32,69,120,127],"unmet":[33],"significant":[35],"therapeutic":[36],"need":[37],"for":[38,126,157,170],"patients":[39,54],"COPD.":[41],"GALATHEA":[42,95],"(NCT02138916)":[43],"TERRANOVA":[45,97],"(NCT02155660)":[46],"were":[47],"trials":[48,98],"assessing":[49],"efficacy":[50],"benralizumab":[52,66,109],"frequent":[56,142],"COPD":[57,79,112,171],"despite":[59,145],"treatment.":[60],"Although":[61],"these":[62],"studies":[63],"found":[64],"that":[65],"given":[67],"as":[68],"add-on":[70],"treatment":[71,107],"did":[72],"not":[73],"significantly":[74],"reduce":[75],"annual":[76],"rates":[77],"after":[81],"56":[82],"weeks":[83],"treatment,":[85],"the":[87,94,152,165],"following":[88,119],"exploratory":[89],"post":[90],"hoc":[91],"analysis":[92],"we":[99],"identified":[100],"a":[101,123],"potential":[102],"responder":[103,132],"population":[104,133],"prevents":[110],"during":[114],"30-":[115],"90-day":[117],"periods":[118],"initial":[121],"exacerbation,":[122],"vulnerable":[124],"period":[125],"exacerbation":[128],"occur.":[130],"This":[131],"was":[134],"characterized":[135],"by":[136],"blood":[138],"eosinophil":[139],"counts":[140],"previous":[143],"optimized":[146],"triple":[147],"therapy.":[148],"These":[149],"results":[150],"highlight":[151],"importance":[153],"targeted":[155],"therapies":[156,169],"high-risk":[158],"populations":[159],"merit":[161],"further":[162],"research":[163],"into":[164],"benefits":[166],"biologic":[168],"exacerbations.":[172]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}